Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua F Zeidner

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid LeukemiaJoshua F Zeidner, Daniel J Lee, Mark Frattini, et al.
JAMA Oncology|September 22, 2022
Association of QTc Formula With the Clinical Management of Patients With CancerDaniel R Richardson, P Christopher Parish, Xianming Tan, et al.
Leukemia & Lymphoma|May 12, 2018
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatmentMeera Yogarajah, Nathan Montgomery, Melissa Matson, et al.
British Journal of Haematology|October 18, 2019
Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemiaSonia Esparza, Benyam Muluneh, Jonathan Galeotti, et al.
Haematologica|December 7, 2022
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromesJoshua F Zeidner, Flora Mazerolle, Jonathan Norton, et al.
Leukemia & Lymphoma|June 21, 2021
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatmentLori A Ramkissoon, Kaitlyn Buhlinger, Angela Nichols, et al.
Blood Advances|September 28, 2021
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutationsNathan D Montgomery, Jonathan Galeotti, Steven M Johnson, et al.
Nature Biomedical Engineering|April 25, 2019
Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacyQuanyin Hu, Wujin Sun, Jinqiang Wang, et al.
Hemasphere|January 17, 2020
Acute Myeloid Leukemia with Co-mutated <i>ASXL1</i> and <i>SRSF2</i> Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic LeukemiaSteven M Johnson, Daniel R Richardson, Jonathan Galeotti, et al.
The Annals of Pharmacotherapy|September 20, 2021
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid LeukemiaAndy H Szeto, Tyler Bucci, Allison Deal, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid LeukemiaJoshua F Zeidner, Daniel J Lee, Mark Frattini, et al.
JAMA Oncology|September 22, 2022
Association of QTc Formula With the Clinical Management of Patients With CancerDaniel R Richardson, P Christopher Parish, Xianming Tan, et al.
Leukemia & Lymphoma|May 12, 2018
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatmentMeera Yogarajah, Nathan Montgomery, Melissa Matson, et al.
British Journal of Haematology|October 18, 2019
Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemiaSonia Esparza, Benyam Muluneh, Jonathan Galeotti, et al.
Haematologica|December 7, 2022
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromesJoshua F Zeidner, Flora Mazerolle, Jonathan Norton, et al.
Leukemia & Lymphoma|June 21, 2021
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatmentLori A Ramkissoon, Kaitlyn Buhlinger, Angela Nichols, et al.
Blood Advances|September 28, 2021
Bilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutationsNathan D Montgomery, Jonathan Galeotti, Steven M Johnson, et al.
Nature Biomedical Engineering|April 25, 2019
Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacyQuanyin Hu, Wujin Sun, Jinqiang Wang, et al.
Hemasphere|January 17, 2020
Acute Myeloid Leukemia with Co-mutated <i>ASXL1</i> and <i>SRSF2</i> Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic LeukemiaSteven M Johnson, Daniel R Richardson, Jonathan Galeotti, et al.
The Annals of Pharmacotherapy|September 20, 2021
Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid LeukemiaAndy H Szeto, Tyler Bucci, Allison Deal, et al.
Pageof 8